NCT05938374 2025-12-11
SPARE-03
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Completed
Clinical Trials
4 trialsNCT06827717 2025-05-31
Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma
Sun Yat-sen University
Phase 2 Recruiting
NCT05894018 2025-05-13
RAFAS-001
Sun Yat-sen University
Phase 2 Recruiting
NCT06074692 2023-10-31
PRIMA
Ruijin Hospital
Phase 2 Recruiting